tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders StocksMarket MoversTipRanks Momentum IndexDividend StocksAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Pro Newsletters
Smart Investor
Popular
Smart Growth
New
Research Tools
Trending StocksCompare StocksCompare ETFsMost Visited Websites
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Education
Personal FinanceHow To Use TipRanksTipRanks LabsWebinar CenterGlossaryFAQs
About Us
About TipRanksContact UsCareersReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an AffiliateTipRanks News WireArrivedEquityMultiple
Follow Us
TOOLS
News
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Notification Center
Top ETFs
Top Smart Score Stocks
Popular
Earnings
Plans & Pricing
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders Stocks
Market Movers
TipRanks Momentum Index
Dividend Stocks
AI Stocks
Largest Companies by Market Cap
ETFs
ETF Center
Top ETFs by Upside
New
Top ETFs by Smart Score
Top Gainers/ Losers/ Active ETFs
Options
Options Market Overview
Unusual Options Activity
Popular
Most Active Options
Options Volume Leaders
Commodities
Gold
New
Crypto
Crypto Center
Bitcoin
Popular
Ethereum
Currency
Currency Center
EUR/USD
Pro Newsletters
Smart Investor
Popular
Research Tools
Trending Stocks
Compare Stocks
Compare ETFs
Most Visited Websites
Daily Feeds
Daily Analyst Ratings
Daily Insider Trading Tracker
Calendars
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Economic Indicators
Economic Indicators Center
Inflation Rate
Unemployment Rate
Federal Funds Rate
Class Actions
Class Actions
Calculators
Dividend Calculator
Dividend Yield Calculator
Options Profit Calculator
Dollar Cost Averaging
New
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
News
Portfolio
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Calculators
Compound Interest Calculator
New
Mortgage Calculator
Popular
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Enterprise Solutions
Education
How To Use TipRanks
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
Corbus Pharmaceuticals (CRBP)
NASDAQ:CRBP
US Market
CRBP
Corbus Pharmaceuticals
Overview
Analyst Forecasts
Financials
Dividends
Technical Analysis
Options
Chart
Earnings
Ownership
Similar Stocks
RESEARCH TOOLS
Top Analyst Stocks
Top Smart Score Stocks
Stock Screener
reports

Corbus Pharmaceuticals (CRBP) Stock News & Sentiment

Compare
2,338 Followers
Promising Potential of Corbus Pharmaceuticals’ CRB-701 in Oncology: A Strong Buy Rating by Andrew Fein
Premium
Ratings
Promising Potential of Corbus Pharmaceuticals’ CRB-701 in Oncology: A Strong Buy Rating by Andrew Fein
5d ago
CRBP
Corbus Pharmaceuticals Reports Promising Phase 1 Trial Results
Premium
Company Announcements
Corbus Pharmaceuticals Reports Promising Phase 1 Trial Results
9d ago
8K
CRBP
Corbus Pharmaceuticals Advances with FDA Fast Track Designation
Premium
Company Announcements
Corbus Pharmaceuticals Advances with FDA Fast Track Designation
3M ago
8K
CRBP
Corbus Pharmaceuticals Reports Q3 2024 Financials and Updates
Premium
Company Announcements
Corbus Pharmaceuticals Reports Q3 2024 Financials and Updates
4M ago
CRBP
Corbus Pharmaceuticals Reports Q3 2024 Financial Results
Premium
Company Announcements
Corbus Pharmaceuticals Reports Q3 2024 Financial Results
4M ago
8K
CRBP
Corbus Pharmaceuticals Reveals Promising Obesity Treatment Data
Premium
Company Announcements
Corbus Pharmaceuticals Reveals Promising Obesity Treatment Data
4M ago
8K
CRBP
CRBP Upcoming Earnings Report: What to Expect?
Premium
Pre-Earnings
CRBP Upcoming Earnings Report: What to Expect?
4M ago
CRBP
More CRBP News >

CRBP News on the Web

Mizuho Securities Reaffirms Their Buy Rating on Corbus Pharmaceuticals (CRBP)
TipRanks News
Bullish
Corbus Pharmaceuticals Highlights Data From Its First US-Based Trial Of Lead Cancer Drug Candidate
Yahoo Finance
Neutral
CRB-701 A Next Generation Nectin-4 Targeting ADC Demonstrates Encouraging Safety and Broader Efficacy in Phase 1 Study in the US and UK Presented at ASCO-GU 2025
Yahoo Finance
Neutral
Corbus Pharmaceuticals (CRBP) Receives a Buy from RBC Capital
TipRanks News
Bullish
Buy Rating for Corbus Pharmaceuticals on Promising CRB-913 Obesity Treatment and Favorable Risk/Reward Scenario
TipRanks News
Bullish
These 9 biotech stocks have doubled this year and are set to double again, analysts say
CNBC
Neutral
Corbus Announces Enrollment Completion of Dose Escalation Stage of Phase 1 Clinical Trial of Its Next Generation Nectin-4 Targeting ADC
Yahoo Finance
Neutral
Ikarian Capital, LLC Adjusts Stake in Avalo Therapeutics Inc
GuruFocus News
Neutral

News Score - Last 7 Days

Neutral
CRBP
Sector Average
Media Buzz
This Week1 articles
Weekly Average1 articles
News Sentiment
This Week100%
Sector Average57%
See how Bullish or Bearish a stock is based on its recent media coverage.

This score is generated using a formula that combines Media Buzz and News Sentiment.

Media Coverage Analysis

The historical news coverage of this asset in the last three months.

FAQ

What is CRBP’s Media Buzz Sentiment?
1 articles about CRBP were published this week. In an average week, 1 articles are published.
    What is CRBP’s weekly average amount of articles?
    In an average week, 1 articles about CRBP are published.
      What is CRBP’s News Sentiment?
      100% of articles about CRBP were positive this week, compared to its sector average of 57%.
        Healthcare Stocks that are Trending in the News
        HCMHUTCHMED
        PENPenumbra
        AMNAMN Healthcare Services
        BNTCBenitec Biopharma
        IMUXImmunic
        Showing the stocks with the most bullish news sentiment over the past week

        Become an Expert with TipRanks Premium

        What am I Missing?
        Make informed decisions based on Top Analysts' activity
        Know what industry insiders are buying
        Get actionable alerts from top Wall Street Analysts
        Find out before anyone else which stock is going to shoot up
        Get powerful stock screeners & detailed portfolio analysis
        Subscribe NowSee Plans & Pricing